Molecule blocks cholesterol and ‘kills breast cancer cells’

The molecule Ro 48-8071, initially developed for controlling cholesterolA substance present in many tissues and an important constituent of cell membranes although high concentrations of a certain type of cholesterol in the blood are unhealthy. synthesis, can also ‘destroy’ human breast cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body. cells according to Salmon Hyder, Professor of Biomedical Sciences at the College of Veterinary Medicine, and the Dalton Cardiovascular Research Centre.

The molecule and its effects were discovered whilst conducting research into PRIMA-1, a drug which targets a common mutated geneThe basic unit of genetic material carried on chromosomes. in human breast cancer cells, and kills the tumourAn abnormal swelling. cells. Research into PRIMA-1 identified excellent binding properties to the proteinCompounds that form the structure of muscles and other tissues in the body, as well as comprising enzymes and hormones. Oxidosqualene Cyclase, which is important for producing cholesterol. These findings encouraged the research into Ro 48-8071 to stop cholesterol production and kill breast cancer cells.

Testing has identified that the mechanism utilised by PRIMA-1 to kill cancer cells may include shutting down cholesterol synthesis. The molecule Ro 48-8071 which was researched due to these results also stops cholesterol synthesis, and proved to be just as effective in destroying cancer cells as PRIMA-1, however without causing any harm to normal breast cells.

The results of this study are published in an article “An inverse docking approach identifying new potential anti-cancer targets” in the February Journal of Molecular Graphics and Modeling. 

Continuous improvement requires feedback and your opinions count. Do you have a few minutes to tell us what you think about this site?

Yes
No